BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Systematix Research Report
Apollo Pipes Ltd. Q2 profit after tax missed estimates on lower-than-expected Ebitda (9.7%, Rs 12.2/kg), despite 28% rise in volume. Management has guided for a low ~Rs 13/kg Ebitda in coming quarters due to aggressive plans for hiring and advertising and promotion expense. A Rs 5 billion capex is planned over FY24-26 to double capacity to ~290 kilo tonne and achieve 30% volume compound annual growth rate.
Plants in the Eastern Uttar Pradesh and Maharashtra, at Rs 1.35 billion capex each, is likely to be operation in H2 FY25. Considering Apollo Pipes’ H1 FY24 performance and management’s focus for volumes over margins, we have cut FY24E/25E earnings estimates by 22%/15% mainly on lower than earlier estimated Ebitda per kg (~Rs 13 now versus Rs 16-18 earlier, as guided by the management).
We now estimate 31%/27%/51%/98% CAGR in volume / revenue /Ebitda/profit after tax over FY23-25E, with return on capital employed of ~17% in FY25E.
We expect Apollo Pipes to retain its fast-growing status, driven by pan-India aspirations and richer product mix towards non-agri value added product. Doubling of capacities in three-four years at Rs 5 billion capex and expansion in distribution should help the company in attaining its pan-India goals.
Considering its robust prospects, we maintain our 'Buy' rating on the stock, with a revised target price of Rs 760 (earlier Rs 896), based on 32 times FY25E price/earning.
While Apollo Pipes has maintained its industry leading volume growth status, margin trajectory is the key monitorable in coming quarters.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
RECOMMENDED FOR YOU
![](https://images.assettype.com/bloombergquint/2023-08/f913e355-f61b-4384-b717-b86bb4b7a5cf/Raymond_website.jpg?rect=0%2C0%2C3500%2C1969&auto=format%2Ccompress&format=webp&w=75)
How Is The Share Price Of Raymond Lifestyle Valued
![timelogo](/images/amp-time.png)
![](https://images.assettype.com/bloombergquint/2023-11/73b1503b-8ffc-4718-a6b6-a99e6a1bb8ec/pipe_img.webp?rect=0%2C0%2C3500%2C1969&auto=format%2Ccompress&format=webp&w=75)
Welspun Approves $100 Million Investment To Enhance US Pipe Manufacturing Capabilities
![timelogo](/images/amp-time.png)
![](https://images.assettype.com/bloombergquint/2024-05/8fb9fed6-c207-40b8-9d36-f960dfc64514/Apollo_Hospitals_Enterprise_website.jpg?rect=0%2C0%2C3500%2C1969&auto=format%2Ccompress&format=webp&w=75)
Apollo Hospitals Q1 Results Review - Superior Execution Across Segments: Motilal Oswal
![timelogo](/images/amp-time.png)
![](https://images.assettype.com/bloombergquint/2022-01/5c116ab0-a6e8-4937-8859-f8b6611fc85c/Range_of_Apollo_Pipes___Source_Company_website_.png?rect=0%2C0%2C3500%2C1969&auto=format%2Ccompress&format=webp&w=75)
Apollo Pipes Q1 Review - Tepid Results; Robust Guidance Intact Though: Systematix
![timelogo](/images/amp-time.png)